Page last updated: 2024-08-23

raloxifene hydrochloride and Deep Vein Thrombosis

raloxifene hydrochloride has been researched along with Deep Vein Thrombosis in 19 studies

Research

Studies (19)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (5.26)	18.2507
2000's	15 (78.95)	29.6817
2010's	3 (15.79)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dahm, AEA; Eilertsen, AL; Høibraaten, E; Lofthus, CM; Mowinckel, MC; Sandset, PM	1
Inoue, D	1
Ando, H; Fujimura, A; Hosohata, K; Inano, A; Kaneko, S; Matsushita, E; Nagai, Y; Ookami, H; Otoda, T; Saito, T; Takamura, T; Ushijima, K	1
Forsmo, S; Skolbekken, JA	1
Yendt, ER	1
Azevedo, GD; Baggio, MS; Ferriani, RA; Franco, RF; Maranhão, TM; Silva de Sá, MF	1
Itabashi, A	1
Ciaccia, A; Cummings, S; Ettinger, B; Grady, D; Moscarelli, E; Plouffe, L; Sarkar, S	1
Higuchi, T; Mizunuma, H	1
Morii, H	1
Disch, D; Dowsett, SA; Keech, CA; Martino, S; Mershon, JL	1
Eilertsen, AL; Hemker, HC; Liestøl, S; Mowinckel, MC; Sandset, PM	1
Nakamura, T	1
Adomaityte, J; Farooq, M; Qayyum, R	1
Agnusdei, D; Iori, N	1
Gradishar, WJ; O'Regan, RM	1
Cauley, JA; Cummings, SR; Duong, T; Kenyon, E; Krueger, KA; Whitehead, M	1
Grady, D	1

Reviews

8 review(s) available for raloxifene hydrochloride and Deep Vein Thrombosis

Article	Year
[Effects of SERMs on bone health. Raloxifene effects on breast cancer and cardiovascular events]. Clinical calcium, 2010, Volume: 20, Issue:3 Topics: Arteriosclerosis; Breast Neoplasms; Female; Humans; Osteoporosis, Postmenopausal; Pulmonary Embolism; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Stroke; Venous Thrombosis	2010
Chemoprevention of breast cancer: recommendations and rationale. American family physician, 2003, Mar-15, Volume: 67, Issue:6 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Estrogen Antagonists; Evidence-Based Medicine; Female; Humans; Practice Guidelines as Topic; Quality of Life; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Tamoxifen; Venous Thrombosis	2003
[MORE study(raloxifene)]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 2 Topics: Biomarkers; Bone Density; Breast Neoplasms; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Multicenter Studies as Topic; Osteocalcin; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Spinal Fractures; Treatment Outcome; Venous Thrombosis	2004
[Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases]. Clinical calcium, 2004, Volume: 14, Issue:10 Topics: Breast Neoplasms; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Receptors, Estrogen; Risk; Selective Estrogen Receptor Modulators; Venous Thrombosis	2004
[Safety profile of raloxifene]. Clinical calcium, 2004, Volume: 14, Issue:10 Topics: Asian People; Clinical Trials as Topic; Female; Hot Flashes; Humans; Leg; Muscle Cramp; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Venous Thrombosis; White People	2004
[Adverse events of drugs for the treatment of osteoporosis]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8 Topics: Bone Density Conservation Agents; Cardiovascular Diseases; Cholecalciferol; Diphosphonates; Gastrointestinal Diseases; Hot Flashes; Humans; Hypercalcemia; Jaw Diseases; Macular Edema; Necrosis; Osteoporosis; Raloxifene Hydrochloride; Venous Thrombosis	2007
Effect of raloxifene therapy on venous thromboembolism in postmenopausal women. A meta-analysis. Thrombosis and haemostasis, 2008, Volume: 99, Issue:2 Topics: Aged; Bone Density Conservation Agents; Female; Humans; Middle Aged; Odds Ratio; Osteoporosis, Postmenopausal; Patient Selection; Postmenopause; Pulmonary Embolism; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis	2008
Tolerability profile of SERMs. Journal of endocrinological investigation, 1999, Volume: 22, Issue:8 Topics: Animals; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Venous Thrombosis	1999

Trials

6 trial(s) available for raloxifene hydrochloride and Deep Vein Thrombosis

Article	Year
Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2019, Volume: 30, Issue:1 Topics: Activated Protein C Resistance; Blood Coagulation; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Sex Hormone-Binding Globulin; Venous Thrombosis	2019
Dosing time-dependent effect of raloxifene on plasma plasminogen activator inhibitor-1 concentrations in post-menopausal women with osteoporosis. Clinical and experimental pharmacology & physiology, 2013, Volume: 40, Issue:3 Topics: Aged; Aged, 80 and over; Biological Factors; Circadian Rhythm; Drug Administration Schedule; Female; Fibrinolysis; Humans; Osteoporosis, Postmenopausal; Plasminogen Activator Inhibitor 1; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome; Venous Thrombosis	2013
Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation. Obstetrics and gynecology, 2004, Volume: 104, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Incidence; Middle Aged; Multicenter Studies as Topic; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; United States; Venous Thrombosis	2004
Safety assessment of raloxifene over eight years in a clinical trial setting. Current medical research and opinion, 2005, Volume: 21, Issue:9 Topics: Aged; Bone Density; Cardiovascular System; Double-Blind Method; Female; Follow-Up Studies; Humans; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Raloxifene Hydrochloride; Safety; Selective Estrogen Receptor Modulators; Venous Thrombosis	2005
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system. Thrombosis and haemostasis, 2007, Volume: 97, Issue:6 Topics: Activated Protein C Resistance; Administration, Oral; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Protein C; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tablets; Thromboembolism; Treatment Outcome; Venous Thrombosis	2007
Serum estradiol level and risk of breast cancer during treatment with raloxifene. JAMA, 2002, Jan-09, Volume: 287, Issue:2 Topics: Aged; Breast Neoplasms; Estradiol; Female; Hot Flashes; Humans; Osteoporosis, Postmenopausal; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk; Selective Estrogen Receptor Modulators; Spinal Fractures; Venous Thrombosis	2002

Other Studies

5 other study(ies) available for raloxifene hydrochloride and Deep Vein Thrombosis

Article	Year
[Absolutely not true and relatively true about risk reduction]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2003, Jan-09, Volume: 123, Issue:1 Topics: Advertising; Drug Information Services; Estrogen Antagonists; Female; Fractures, Spontaneous; Humans; Odds Ratio; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Reduction Behavior; Venous Thrombosis	2003
Osteoporosis guidelines. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2003, Jun-24, Volume: 168, Issue:13 Topics: Aged; Canada; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Practice Guidelines as Topic; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Venous Thrombosis	2003
Effects of raloxifene therapy on the anticoagulant system in postmenopausal women. Climacteric : the journal of the International Menopause Society, 2003, Volume: 6, Issue:2 Topics: Aged; Antithrombins; Female; Humans; Longitudinal Studies; Middle Aged; Postmenopause; Prospective Studies; Protein C; Protein S; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Venous Thrombosis	2003
Selective estrogen-receptor modulators in 2001. Oncology (Williston Park, N.Y.), 2001, Volume: 15, Issue:9 Topics: Breast Neoplasms; Clinical Trials as Topic; Endometrial Neoplasms; Estrogen Antagonists; Female; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Pilot Projects; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Venous Thrombosis	2001
A 60-year-old woman trying to discontinue hormone replacement therapy. JAMA, 2002, Apr-24, Volume: 287, Issue:16 Topics: Alendronate; Breast Neoplasms; Contraindications; Coronary Disease; Decision Making; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrocystic Breast Disease; Hot Flashes; Humans; Hysterectomy; Middle Aged; Osteoporosis, Postmenopausal; Ovariectomy; Raloxifene Hydrochloride; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen; Venous Thrombosis	2002